Conferences are held Mondays 1–2 p.m. via Teams unless noted. Core curriculum lectures are in bold.
| Date | Topic | Speaker |
| Sept. 8 | LDL-C–lowering medications | Vijay Nambi |
| Sept. 15 | Triglycerides: what works now and what will in the future | Christie Ballantyne |
| Sept. 22 | Cardiometabolic disease: why the time to focus is now | Layla Abushamat |
| Sept. 29 | TBD | TBD |
| Oct. 6 | HDL: current relevance in CVD (part 1) | Baiba Gillard |
| Oct. 13 | HDL: current relevance in CVD (part 2) | Henry Pownall |
| Oct. 20 | Journal Club | Yakubu Bene-Alhasan |
| Oct. 27 | Hypertension management | Addison Taylor |
| Nov. 3 | AHA prep | open |
| Nov. 17 | AHA review | Yakubu Bene-Alhasan |
| Dec. 1 | Cardiovascular risk stratification | José Rivas |
| Dec. 8 | Metabolomics and proteomics | Bing Yu |
| Jan. 12 | Management of inflammation in CVD prevention | Christie Ballantyne |
| Jan. 26 | Journal Club | Yakubu Bene-Alhasan |
| Feb. 2 | Weight loss strategies | Layla Abushamat |
| Feb. 9 | Biomarkers and CVD | Ron Hoogeveen |
| Feb. 16 | Macrophages, monocytes, and CVD | Huaizhu Wu |
| Feb. 23 | Lipoprotein(a) | Anandita Agarwal |
| March 2 | CAC scoring, CT scanning, and atherosclerosis | Mahmoud Al Rifai |
| March 9 | Pediatric lipid management | Justin Zachariah |
| March 16 | Aging, brain health, and atherosclerosis | Anum Saeed |
| March 23 | ACC prep | open |
| April 6 | ACC review | Yakubu Bene-Alhasan |
| April 13 | Journal Club | Yakubu Bene-Alhasan |
| April 20 | Residual risk | Vijay Nambi |
| April 27 | Journal Club | Yakubu Bene-Alhasan |
| May 4 | Make up | |
| May 11 | Year in review: my research | Yakubu Bene-Alhasan |